1Y Close · As of Aug 26, 2026
Genomictree operates in the Professional Services sector.
Legal name: Genomictree Inc.
In fiscal year 2025, Genomictree (228760) reported revenue of 3.8 billion KRW, up 59.2% from 2.4 billion KRW a year earlier.
Operating profit was -11.3 billion KRW and net income was -9.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 298.3 billion KRW, with a P/B of 2.59.
These figures can be verified in the DART filing (receipt no. 20260318001270).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 3.8B | -11.3B | -9.1B |
| 2024 | 2.4B | -15.3B | -10.4B |
| 2023 | 3.4B | -17.3B | -9.0B |
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 2 disposal(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-20 | Corporate Briefing (IR) |
| 2026-08-14 | Semi-Annual Report (2026.06) |